Abbreviations used in these recommendations
BNF | British National Formulary |
CASP | critical appraisal skills programme |
CEAC | cost-effectiveness acceptability curve |
CGM | continuous glucose monitoring |
CI | confidence interval |
CLOuD |
closed loop from onset in type 1 diabetes |
CSII | continuous subcutaneous insulin infusion |
CVD | cardiovascular disease |
DCCT | UK diabetes control and complications trial |
DDS | diabetes distress scale |
ESRD | end stage renal disease |
FGM | flash glucose monitoring |
GRADE | grading of recommendations assessment, development and evaluation |
HCHS | hospital and community health services |
HCL | hybrid closed loop |
HDL:TCL | high density lipoprotein : total cholesterol levels |
ICER | incremental cost-effectiveness ratio |
iPAG | Insulin Pump Awareness Group |
IQR | inter-quartile range |
JDRF | Juvenile Diabetes Research Foundation |
LY | life years |
MD | mean difference |
MDI | multiple daily injections |
NHSEED | NHS economic evaluations database |
NICE | National Institute for Health and Care Excellence |
NMA | network meta-analysis |
NSHE | non-severe hypoglycaemic event |
OR | odds ratio |
PAD | peripheral arterial disease |
PAID | problem areas in diabetes |
PRO | patient reported outcomes |
QALY | quality adjusted life years |
RCT | randomised controlled trial |
RR | relative risk/risk ratio |
SCI | Scottish care information |
SD | standard deviation |
SE | standard error |
SHE | severe hypoglycaemic event |
SHTG | Scottish Health Technologies Group |
SIMD | Scottish index of multiple deprivation |
SMBG | self monitoring blood glucose |
SUCRA | surface under the cumulative ranking |
TBR | time below range |
TIR | time in range |
UKPDS | UK prospective diabetes study |
WESDR | Wisconsin epidemiological study of diabetic retinopathy |
WMD | weighted mean difference |